Is It Worth Continuing Sexual Rehabilitation after Radical Prostatectomy with Intracavernous Injection of Alprostadil for More than 1 Year?
Open Access
- 1 March 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Sexual Medicine
- Vol. 3 (1) , 42-48
Abstract
Introduction Intracavernous alprostadil injection (IAI) is a widely used treatment for sexual rehabilitation (SR) after radical prostatectomy (RP). It is unknown whether the continuation of IAI beyond 1 year continues to improve erectile function. Aims To assess evolution of sexual function in patients using IAI who are nonresponsive to phosphodiesterase type 5 inhibitors (PDE5i) between 12 (M12) and 24 (M24) months after RP. Methods We retrospectively studied 75 men with a nerve-sparing laparoscopic RP, who had normal preoperative erectile function, and who regularly used IAI for SR for at least 24 months. At M12, no patients had responded to PDE5i. Main Outcome Measures At 12 and 24 months, sexual function was assessed with the UCLA Prostate Cancer Index (UCLA-PCI), International Index of Erectile Function (IIEF)-15, and erection hardness score (EHS) with and without IAI. We also assessed the satisfaction rate with IAI, injection-related penile pain, and satisfaction of treatment. Statistical analysis was performed by using t-tests for paired data and Spearman's rho correlation coefficients to assess the relationships between scores at M12 and M24. Results Improvement of nocturnal erection was noted (UCLA-PCI, question 25); however, no significant difference was found for IIEF-erectile function with (19.60 ± 9.80 vs. 18.07 ± 10.44) and without IAI (4.63 ± 2.93 vs. 4.92 ± 4.15), UCLA-PCI-sexual bother (37.14 ± 21.45 vs. 37.54 ± 19.67), nor the EHS score with (2.97 ± 1.30 vs. 2.57 ± 1.30) and without IAI (0.67 ± 1.11 vs. 0.76 ± 0.10). The rate of satisfaction with treatment decreased over time (66.6% vs. 46.7%, P = 0.013). Improved response to IAI at M12 was not correlated to improvement in spontaneous erections at M24. Conclusion The response to IAI remained stable after 2 years of treatment, and no significant improvement of spontaneous erections during intercourse attempts was found between M12 and M24. Patients should be informed of the limited effect of IAI on natural erections after 1 year. Yiou R, Bütow Z, Parisot J, Binhas M, Lingombet O, Augustin D, de la Taille A, and Audureau E. Is it worth continuing sexual rehabilitation after radical prostatectomy with intracavernous injection of alprostadil for more than 1 year? Sex Med 2015;3:42–48.Keywords
This publication has 29 references indexed in Scilit:
- Standard Operating Procedure for the Preservation of Erectile Function Outcomes After Radical ProstatectomyThe Journal of Sexual Medicine, 2013
- Erectile Function Rehabilitation in the Radical Prostatectomy PatientThe Journal of Sexual Medicine, 2010
- The timing of penile rehabilitation after bilateral nerve‐sparing radical prostatectomy affects the recovery of erectile functionBJU International, 2009
- Post-Radical Prostatectomy Pharmacological Penile Rehabilitation: Practice Patterns Among the International Society for Sexual Medicine PractitionersThe Journal of Sexual Medicine, 2009
- Acceptance of and Discontinuation Rate from Erectile Dysfunction Oral Treatment in Patients following Bilateral Nerve-Sparing Radical ProstatectomyEuropean Urology, 2008
- How Urologists Manage Erectile Dysfunction after Radical Prostatectomy: A National Survey (REPAIR) by the French Urological AssociationThe Journal of Sexual Medicine, 2008
- Intracavernous Injections of Prostaglandin E1 for Erectile Dysfunction: Patient Satisfaction and Quality of Sex Life on Long-Term TreatmentThe Journal of Sexual Medicine, 2007
- Sexual Counseling Improved Erectile Rehabilitation After Non-Nerve-Sparing Radical Retropubic Prostatectomy or Cystectomy—Results of a Randomized Prospective StudyThe Journal of Sexual Medicine, 2006
- The Use of an Erectogenic Pharmacotherapy Regimen Following Radical Prostatectomy Improves Recovery of Spontaneous Erectile FunctionThe Journal of Sexual Medicine, 2005
- The UCLA Prostate Cancer IndexMedical Care, 1998